{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:03:24Z","timestamp":1788915804129,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"China Mega-Project for Infectious Disease","award":["2012ZX10004701003"],"award-info":[{"award-number":["2012ZX10004701003"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.vaccine.2019.06.078","type":"journal-article","created":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T11:15:29Z","timestamp":1561806929000},"page":"4477-4484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Ag85b\/ESAT6-CFP10 adjuvanted with aluminum\/poly-IC effectively protects guinea pigs from latent mycobacterium tuberculosis infection"],"prefix":"10.1016","volume":"37","author":[{"given":"Chunhua","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbiao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1155-9128","authenticated-orcid":false,"given":"Xuguang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baowen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10100","key":"10.1016\/j.vaccine.2019.06.078_b0005","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Naghavi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.06.078_b0010","unstructured":"World Health Organization. Global tuberculosis report 2018, http:\/\/www.who.int\/tb\/publications\/global_report\/en\/; 2018 [accessed 18 September 2018]."},{"issue":"1","key":"10.1016\/j.vaccine.2019.06.078_b0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1574-695X.2010.00660.x","article-title":"The development and preliminary evaluation of a new Mycobacterium tuberculosis vaccine comprising Ag85b, HspX and CFP-10:ESAT-6 fusion protein with CpG DNA and aluminum hydroxide adjuvants","volume":"59","author":"Chen","year":"2010","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.06.078_b0020","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/clinids\/20.1.126","article-title":"Relationship between bacille Calmette-Gu\u00e9rin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis","volume":"20","author":"Brewer","year":"1995","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2019.06.078_b0025","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"issue":"8986","key":"10.1016\/j.vaccine.2019.06.078_b0030","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2019.06.078_b0035","first-page":"128","article-title":"The tuberculosis epidemic: scientific challenges and opportunities","volume":"113","author":"Ginsberg","year":"1998","journal-title":"Public Health Rep"},{"issue":"9517","key":"10.1016\/j.vaccine.2019.06.078_b0040","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.06.078_b0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g4643","article-title":"Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis","volume":"349","author":"Roy","year":"2014","journal-title":"BMJ"},{"issue":"37","key":"10.1016\/j.vaccine.2019.06.078_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17370","article-title":"Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guerin vaccination against tuberculosis","volume":"17","author":"Abubakar","year":"2013","journal-title":"Health Technol Assess"},{"issue":"1","key":"10.1016\/j.vaccine.2019.06.078_b0055","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of bacillus Calmette-Guerin vaccination of newborn and infants in the prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.vaccine.2019.06.078_b0060","doi-asserted-by":"crossref","first-page":"470e80","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2019.06.078_b0065","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1080\/21645515.2018.1458806","article-title":"The current status, challenges, and future developments of new tuberculosis vaccines","volume":"14","author":"Gong","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"10.1016\/j.vaccine.2019.06.078_b0070","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/resp.13245","article-title":"Tuberculosis vaccines: opportunities and challenges","volume":"23","author":"Zhu","year":"2018","journal-title":"Respirology"},{"key":"10.1016\/j.vaccine.2019.06.078_b0075","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijid.2016.10.018","article-title":"Novel approaches to tuberculosis vaccine development","volume":"56","author":"Kaufmann","year":"2017","journal-title":"Int J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2019.06.078_b0080","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1128\/IAI.56.12.3310-3312.1988","article-title":"Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines","volume":"56","author":"Orme","year":"1988","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2019.06.078_b0085","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1073\/pnas.92.5.1530","article-title":"Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis","volume":"92","author":"Horwitz","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2019.06.078_b0090","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1128\/IAI.69.5.2773-2778.2001","article-title":"Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6","volume":"69","author":"Weinrich Olsen","year":"2001","journal-title":"Infect Immun"},{"issue":"Pt11","key":"10.1016\/j.vaccine.2019.06.078_b0095","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1099\/00221287-144-11-3195","article-title":"A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10)","volume":"144","author":"Berthet","year":"1998","journal-title":"Microbiology"},{"issue":"24","key":"10.1016\/j.vaccine.2019.06.078_b0100","doi-asserted-by":"crossref","first-page":"21598","DOI":"10.1074\/jbc.M201625200","article-title":"Conclusive evidence that the major T-cell antigens of the Mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1:1 complex and characterization of the structural properties of ESAT-6, CFP-10, and the ESAT-6*CFP-10 complex","volume":"277","author":"Renshaw","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2019.06.078_b0105","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1046\/j.1365-2958.2002.03237.x","article-title":"Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti","volume":"46","author":"Pym","year":"2002","journal-title":"Mol Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2019.06.078_b0110","doi-asserted-by":"crossref","first-page":"e80579","DOI":"10.1371\/journal.pone.0080579","article-title":"TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccination","volume":"8","author":"Hoang","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.vaccine.2019.06.078_b0115","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20041690","article-title":"Cytolytic CD8+ T cells recognizing CFP10 are recruited to the lung after Mycobacterium tuberculosis infection","volume":"200","author":"Kamath","year":"2004","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2019.06.078_b0120","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1128\/IAI.62.6.2536-2544.1994","article-title":"Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins","volume":"62","author":"Andersen","year":"1994","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.06.078_b0125","first-page":"502","article-title":"Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis","volume":"85","author":"Roberts","year":"1995","journal-title":"Immunology"},{"issue":"4 Suppl","key":"10.1016\/j.vaccine.2019.06.078_b0130","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1038\/nm1210","article-title":"Targeting the innate immune response with improved vaccine adjuvants","volume":"11","author":"Pashine","year":"2005","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.vaccine.2019.06.078_b0135","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd1176","article-title":"Recent advances in the discovery and delivery of vaccine adjuvants","volume":"2","author":"O'Hagan","year":"2003","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"10.1016\/j.vaccine.2019.06.078_b0140","doi-asserted-by":"crossref","first-page":"683","DOI":"10.4049\/jimmunol.180.2.683","article-title":"Cutting edge: cooperation of IPS-1- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses","volume":"180","author":"Kumar","year":"2008","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2019.06.078_b0145","doi-asserted-by":"crossref","first-page":"e1000373","DOI":"10.1371\/journal.ppat.1000373","article-title":"Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques","volume":"5","author":"Stahl-Hennig","year":"2009","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.vaccine.2019.06.078_b0150","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.0818-9641.2004.01280.x","article-title":"Adjuvant synergy: the effects of nasal coadministration of adjuvants","volume":"82","author":"Moschos","year":"2004","journal-title":"Immunol Cell Biol"},{"issue":"12","key":"10.1016\/j.vaccine.2019.06.078_b0155","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.4049\/jimmunol.172.12.7618","article-title":"Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein","volume":"172","author":"Skeiky","year":"2004","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2019.06.078_b0160","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jmii.2014.03.005","article-title":"Recombinant tuberculosis vaccine AEC\/BC02 induces antigen-specific cellular responses in mice and protects guinea pigs in a model of latent infection","volume":"48","author":"Lu","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.vaccine.2019.06.078_b0165","first-page":"900","article-title":"Establishment and validation of a guinea pig model of latent Mycobacterium tuberculosis infection","volume":"12","author":"Lu","year":"2013","journal-title":"Chin J Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2019.06.078_b0170","series-title":"Modern tuberculosis","author":"Xie","year":"2000"},{"issue":"4","key":"10.1016\/j.vaccine.2019.06.078_b0175","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S2213-2600(18)30057-2","article-title":"The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era","volume":"6","author":"Floyd","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.06.078_b0180","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1186\/1471-2172-14-S1-S13","article-title":"Evaluation of the humoral immune response and cross reactivity against Mycobacterium tuberculosis of mice immunized with liposomes containing glycolipids of Mycobacterium smegmatis","volume":"14","author":"Borrero","year":"2013","journal-title":"BMC Immunol"},{"key":"10.1016\/j.vaccine.2019.06.078_b0185","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coi.2018.04.004","article-title":"Updates on antibody functions in Mycobacterium tuberculosis infection and their relevance for developing a vaccine against tuberculosis","volume":"53","author":"Achkar","year":"2018","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.06.078_b0190","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A functional role for antibodies in tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.vaccine.2019.06.078_b0195","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.immuni.2007.11.003","article-title":"How do adjuvants work? Important considerations for new generation adjuvants","volume":"27","author":"McKee","year":"2007","journal-title":"Immunity"},{"issue":"19","key":"10.1016\/j.vaccine.2019.06.078_b0200","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.vaccine.2008.02.063","article-title":"Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection","volume":"26","author":"Bungener","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.078_b0205","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/S0140-6736(10)60393-5","article-title":"New vaccines for tuberculosis","volume":"375","author":"Kaufmann","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2019.06.078_b0210","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1128\/IAI.66.6.2951-2959.1998","article-title":"Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis","volume":"66","author":"Baldwin","year":"1998","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2019.06.078_b0215","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1128\/IAI.67.7.3242-3247.1999","article-title":"Increase in gamma interferon-secreting CD8(+), as well as CD4(+), T cells in lungs following aerosol infection with Mycobacterium tuberculosis","volume":"67","author":"Feng","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2019.06.078_b0220","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1440-1711.2000.00936.x","article-title":"Role of CD8 T cellsin mycobacterial infections","volume":"78","author":"Smith","year":"2000","journal-title":"Immunol Cell Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.06.078_b0225","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2019.06.078_b0230","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tube.2016.07.005","article-title":"Safety and immunogenicity of the M72\/AS01E candidate tuberculosis vaccine in adults with tuberculosis: a phase II randomised study","volume":"100","author":"Gillard","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"issue":"17","key":"10.1016\/j.vaccine.2019.06.078_b0235","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/j.vaccine.2012.05.035","article-title":"Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72\/AS01 as compared to the M72\/AS02 and Mtb72F\/AS02 tuberculosis candidate vaccine formulations: a randomized trial","volume":"31","author":"Leroux-Roels","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.06.078_b0240","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.vaccine.2019.06.078_b0245","first-page":"4","article-title":"Vaccination strategies against tuberculosis","author":"Andersen","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"12","key":"10.1016\/j.vaccine.2019.06.078_b0250","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1002\/1521-4141(200012)30:12<3689::AID-IMMU3689>3.0.CO;2-4","article-title":"Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells","volume":"30","author":"van Pinxteren","year":"2000","journal-title":"Eur J Immunol"},{"issue":"17","key":"10.1016\/j.vaccine.2019.06.078_b0255","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","article-title":"Phase 2b controlled trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"379","author":"Van Der Meeren","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19308552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19308552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T11:44:00Z","timestamp":1663847040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19308552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":51,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0264410X19308552"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.078","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ag85b\/ESAT6-CFP10 adjuvanted with aluminum\/poly-IC effectively protects guinea pigs from latent mycobacterium tuberculosis infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.06.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}